Evidence map›Paper›PMID 37364279›Full record

ArticleAnesthesiology2023

Presence of Preoperative Neurodegeneration Biofluid Markers in Patients with Postoperative Delirium.

Jacqueline M Leung, Julio C Rojas, Christopher Tang, Brandon Chan, Argentina Lario-Lago, Adam L Boxer, Quyen Do, Joel H Kramer, Zhiyuan Du, Pang Du and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Anesthesiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 4 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 4 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Review
  7. Observational
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 4 countries.

Jacqueline M LeungDepartment of Anesthesia and Perioperative Care, University of California San Francisco, San Francisco, California.ORCID 0000-0002-2008-2491
Julio C RojasMemory and Aging Center, Department of Neurology, Weill institute for Neurosciences, University of California San Francisco, San Francisco, California.
Christopher TangDepartment of Anesthesia and Perioperative Care, University of California San Francisco, San Francisco, California.
Brandon ChanMemory and Aging Center, Department of Neurology, Weill institute for Neurosciences, University of California San Francisco, San Francisco, California.
Argentina Lario-LagoMemory and Aging Center, Department of Neurology, Weill institute for Neurosciences, University of California San Francisco, San Francisco, California.
Adam L BoxerMemory and Aging Center, Department of Neurology, Weill institute for Neurosciences, University of California San Francisco, San Francisco, California.
Quyen DoDepartment of Statistics, Virginia Tech, Blacksburg, Virginia.
Joel H KramerMemory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California.
Zhiyuan DuDepartment of Statistics, Virginia Tech, Blacksburg, Virginia.
Pang DuDepartment of Statistics, Virginia Tech, Blacksburg, Virginia.
Laura P SandsCenter for Gerontology, Virginia Tech, Blacksburg, Virginia.
Perioperative Medicine Research Group
Apple (Israel) · ILUniversity of California, San Francisco · US

Funding

The Alzheimer's Clinical Trial Consortium - Down Syndrome Network (ACTC- DSN)U24AG057437 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Paul S. Aisen, RONALD C PETERSEN · 2018 to 2026
$198.4M
Technology and Remote Assessment CoreU19AG063911 · NIA · MAYO CLINIC ROCHESTER · PI Bradley F Boeve · 2019 to 2026
$120.9M
The Four Repeat Tauopathy Neuroimaging InitiativeR01AG038791 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BOXER, ADAM L. · 2010 to 2020
$18.1M
Mechanisms of Executive Decline in Normal AgingR01AG032289 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Kaitlin B Casaletto, JOEL H KRAMER · 2009 to 2026
$8.3M
Biomarker Evaluation in Young Onset Dementia from Diverse Populations (BEYONDD)R56AG075744 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BOXER, ADAM L., BYRD, DESIREE A · 2022 to 2022
$6.1M
Biological Predictors Of Brain Aging Trajectories Diversity Supplement: African American Outreach And The Intersection Between Social Determinants Of Health And Biomarkers Of Degenerative DiseaseRF1AG032289 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KRAMER, JOEL H · 2020 to 2021
$5.3M
Neurodevelopment in children from families with genetic frontotemporal dementia and Alzheimer’s diseaseR01AG071756 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SUZEE EURIE LEE · 2022 to 2026
$4.1M
Veri-T: A phase 1 Placebo-Controlled Trial of Verdiperstat in Semantic Variant Primary Progressive Aphasia Due to Underlying FTLD-TDPR01AG073482 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ADAM L. BOXER, Peter Alexander Ljubenkov · 2021 to 2026
$3.3M
The role of genomics in postoperative delirium and sedationR01NR017622 · NINR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LEUNG, JACQUELINE M · 2019 to 2021
$2.6M
Validating remote digital assessments for familial frontotemporal dementiaRF1AG077557 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STAFFARONI, ADAM MARK · 2022 to 2022
$2.4M
Proteomics for fluid biomarker discovery in frontotemporal dementiaK23AG059888 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROJAS-MARTINEZ, JULIO CESAR · 2019 to 2023
$995k
The Effects of Light vs Deep Anesthesia on Postoperative Cognitive OutcomesR21AG048456 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LEUNG, JACQUELINE M · 2015 to 2016
$444k
NIA NIH HHS K23 AG059888NIA NIH HHS R01 AG032289NIA NIH HHS R01 AG038791NIA NIH HHS R01 AG071756NIA NIH HHS R01 AG073482NIA NIH HHS R21 AG048456NIA NIH HHS R56 AG075744NIA NIH HHS RF1 AG032289NIA NIH HHS RF1 AG077557NIA NIH HHS U19 AG063911NIA NIH HHS U24 AG057437NINR NIH HHS R01 NR017622
6 · The paper itself

Abstract

backgroundThe pathophysiology of delirium is incompletely understood, including what molecular pathways are involved in brain vulnerability to delirium. This study examined whether preoperative plasma neurodegeneration markers were elevated in patients who subsequently developed postoperative delirium through a retrospective case-control study.

methodsInclusion criteria were patients of 65 yr of age or older, undergoing elective noncardiac surgery with a hospital stay of 2 days or more. Concentrations of preoperative plasma P-Tau181, neurofilament light chain, amyloid β1-42 (Aβ42), and glial fibrillary acidic protein were measured with a digital immunoassay platform. The primary outcome was postoperative delirium measured by the Confusion Assessment Method. The study included propensity score matching by age and sex with nearest neighbor, such that each patient in the delirium group was matched by age and sex with a patient in the no-delirium group.

resultsThe initial cohort consists of 189 patients with no delirium and 102 patients who developed postoperative delirium. Of 291 patients aged 72.5 ± 5.8 yr, 50.5% were women, and 102 (35%) developed postoperative delirium. The final cohort in the analysis consisted of a no-delirium group (n = 102) and a delirium group (n = 102) matched by age and sex using the propensity score method. Of the four biomarkers assayed, the median value for neurofilament light chain was 32.05 pg/ml for the delirium group versus 23.7 pg/ml in the no-delirium group. The distribution of biomarker values significantly differed between the delirium and no-delirium groups (P = 0.02 by the Kolmogorov-Smirnov test) with the largest cumulative probability difference appearing at the biomarker value of 32.05 pg/ml.

conclusionsThese results suggest that patients who subsequently developed delirium are more likely to be experiencing clinically silent neurodegenerative changes before surgery, reflected by changes in plasma neurofilament light chain biomarker concentrations, which may identify individuals with a preoperative vulnerability to subsequent cognitive decline. EDITOR’S PERSPECTIVE:

Indexed as

Emergence DeliriumBiomarkersCase-Control StudiesFemaleHumansMalePostoperative ComplicationsRetrospective StudiesBiomarkers

Identifiers

PMID37364279
PMCPMC10529495
OpenAlexW4382049177

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.